Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
| Image |  |
|---|---|
| Description | scientific article published in September 2006 |
| Author/s |
author: Gerd-Rüdiger Burmester Maxime Dougados Stanley B Cohen Paul Emery |
| Publication date | September 1, 2006 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |